Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use GAMMAGARD LIQUID ERC® safely and effectively. See full prescribing information for GAMMAGARD LIQUID ERC. GAMMAGARD LIQUID ERC [immune globulin infusion (human)]10% solution for intravenous, or subcutaneous use Initial U.S. Approval: 2025
Medication labelWhy this: Advisory · dailymed-other
GAMMAGARD LIQUID ERC is indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age and older. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
- generic_name
- immune globulin infusion (human)
- product_names
- Immune Globulin Infusion (Human)
- ndc
- 0944-2705, 0944-2705-05, 0944-2705-50, 0944-2705-01, 0944-2705-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en